06.10.16

Angelika Berger, Andrea Hölbl-Kovacic
 [Link 1]
Dagmar Gotthardt
 [Link 2]

Angelika Berger, Dagmar Gotthardt and Andrea Hölbl-Kovacic receive "Fonds der Stadt Wien für innovative Krebsforschung"-Awards

The Fonds der Stadt Wien für innovative interdisziplinäre Krebsforschung [Link 3] awards Angelika Berger, Dagmar Gotthardt and Andrea Hölbl-Kovacic for their outstanding scientific works on cancer research.

Angelika Berger and Andrea Hölbl-Kovacic were awarded for their publication "PAK-dependent STAT5 serine phosphorylation is required for BCR-ABL-induced leukemogenesis" [Link 4] which was published in Leukemia [Link 5] in December 2013.

Dagmar Gotthardt was awarded for her publication "Loss of STAT3 in murine NK cells enhances NK cell–dependent tumor surveillance" [Link 6] which was published in Blood [Link 7] in March 2014.

Congratulations!

Link to press release [Link 8]

News archive [Link 9]

 

Welcome to the Institute of Pharmacology and Toxicology

 

Mission

Veronika Sexl
 [Link 10]

Our mission is to discover molecular mechanisms underlying physiological and pathophysiological processes in the organism. This approach is the base for rational drug design, it serves target identification and target validation in modern pharmacological research. Thereby our research offers hope for defeating some of humanity's most devastating diseases-- cancer. The mission of the institute is to perform research and education in molecular, cellular, and clinical pharmacology.

Modern medicine relies on the correct, precise use of drugs. The development of novel therapeutics over the last decades enabled us to cure a wide range of diseases. Yet many aspects still prove difficult and are awaited to be solved! The greatest challenge of our time is to translate the knowledge gathered in this post-genomic era into practice for patient-tailored treatment options - a concept termed as Personalised or Precision Medicine. Pharmacology is not only committed to find out the mechanism of action of drugs but also assists in preparing and understanding how modern drugs can be optimally exploited for the benefit of each patient in the future.

Curriculum Vitae of Veronika Sexl [Link 11]

Research [Link 12]

Publications [Link 13]

 

Recent publications

19.05.16

Eva Maria Putz, Veronika Sexl, et al.
Novel non-canonical role of STAT1 in Natural Killer cell cytotoxicity [Link 14]
Journal: OncoImmunology

11.04.16

Iris Z. Uras, Veronika Sexl, et al.
Palbociclib treatment of FLT3-ITD+ AML cells uncovers a kinase-dependent transcriptional regulation of FLT3 and PIM1 by CDK6 [Link 15]
Journal: Blood

09.02.16

Dagmar Gotthardt, Veronika Sexl et al.
STAT5 is a key regulator in NK cells and acts as molecular switch from tumor surveillance to tumor promotion [Link 16]
Journal: Cancer Discovery


 

Contact

Office: Mon. - Fri. 08:00-14:00

Student affairs: Mon. and Wed. 09:00-11:00

Tel: +43 1 25077 2901
Fax: +43 1 25077 2990
Email: Secretariat [Link 17]

Postal address:

Institute of Pharmacology and Toxicology
Veterinary University of Vienna
A-1210 Vienna, Veterinärplatz 1

Building HA, 3rd floor

Link to directions [Link 18]


 

Appointment with Veronika Sexl only after prior agreement per email: veronika.sexl(at)vetmeduni.ac.at [Link 19]